Abstract:5-aminolevulinic acid photodynamic therapy (ALA-PDT) is an emerging therapeutic strategy for skin cancer due to its noninvasiveness and high spatiotemporal selectivity. However, poor skin penetration, poor intratumoral delivery, the instability of aqueous ALA, and the tumor's inherent hypoxia microenvironment are major hurdles hindering the efficacy of ALA-PDT. Herein, we aim to address these challenges by using microneedles (MNs) to assist in delivering nanoparticles based on natural polymeric tea polyphenols (TP NPs) to self-assemble and load ALA (ALA@TP NPs). The TP NPs specifically increase cellular uptake of ALA by A375 and A431 cells and reduce mitochondrial membrane potential. Subsequently, the photosensitizer protoporphyrin IX derived from ALA accumulates in the tumor cells in a dose-dependent manner with TP NPs, generating reactive oxygen species to promote apoptosis and necrosis of A375 and A431 cells. Interestingly, TP NPs can ameliorate the tumor's inherent hypoxia microenvironment and rapid oxygen consumption during PDT by inhibiting hypoxia inducible factor-1α, thereby boosting reactive oxygen species (ROS) generation and enhancing ALA-PDT efficacy through a positive feedback loop. After ALA@TP NPs are loaded into MNs to fabricate ALA@TP NPs@MNs, the MNs enhance skin penetration and storage stability of ALA. Importantly, they exhibit remarkable antitumor efficacy in A375-induced melanoma and A431-induced squamous cell carcinoma with a reduced dose of ALA and reverse hypoxia in vivo. This study provides a facile and novel strategy that integrates MNs and green NPs of TP for addressing the bottlenecks of ALA-PDT and enhancing the ALA-PDT efficacy against skin cancers for future clinical translation.

Amplifying the Efficacy of ALA-based Prodrugs for Photodynamic Therapy Using Nanotechnology

Tip-loaded Fast-Dissolving Microneedle Patches for Photodynamic Therapy of Subcutaneous Tumor

Zwitterionic Stealth Peptide-Capped 5-Aminolevulinic Acid Prodrug Nanoparticles for Targeted Photodynamic Therapy

Nanoparticles drug delivery for 5-aminolevulinic acid (5-ALA) in photodynamic therapy (PDT) for multiple cancer treatment: a critical review on biosynthesis, detection, and therapeutic applications

Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer

Enhanced 5-Aminolevulinic Acid-Gold Nanoparticle Conjugate-Based Photodynamic Therapy Using Pulse Laser

Design and Proof of Programmed 5-Aminolevulinic Acid Prodrug Nanocarriers for Targeted Photodynamic Cancer Therapy.

In Vitro Evaluation of 5-Aminolevulinic Acid (ala) Loaded Plga Nanoparticles

Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug

Tea polyphenols nanoparticles integrated with microneedles multifunctionally boost 5-aminolevulinic acid photodynamic therapy for skin cancer

[5-Aminolevulinic Acid Esters Based Photodynamic Therapy].

Effectiveness of 5-aminolevulinic Acid-mediated Photodynamic Therapy Combined With Curcumin

Progression of 5-aminolevulinic Acid- based Photodynamic Therapy for Leukemia

Advances in the Treatment of Skin Diseases with Δ-Aminolevulinic Acid-Based Photodynamic Therapy

Dual pH-responsive 5-aminolevulinic acid supramolecular prodrug micelles for enhanced photodynamic ablation of cancer cells

Metal-Organic Layer Delivers 5-Aminolevulinic Acid and Porphyrin for Dual-Organelle-Targeted Photodynamic Therapy

Enhancing Selective Photosensitizer Accumulation and Oxygen Supply for High-Efficacy Photodynamic Therapy Toward Glioma by 5-Aminolevulinic Acid Loaded Nanoplatform

Preparation of ALA‐loaded PLGA Nanoparticles and Its Application in PDT Treatment

Effects of light irradiation upon photodynamic therapy based on 5-aminolevulinic acid-gold nanoparticle conjugates in K562 cells via singlet oxygen generation.

Nanoparticle aided photodynamic therapy (Conference Presentation)

5-Aminolevulinic Acid-Loaded Hyaluronic Acid Dissolving Microneedles for Effective Photodynamic Therapy of Superficial Tumors with Enhanced Long-Term Stability